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Although mesenchymal progenitor cells can be isolated from periodontal ligament (PDL) tissues using stem 
cell markers STRO-1 and CD146, the proportion of these cells that have the capacity to differentiate into mul-
tiple cell lineages remains to be determined. This study was designed to quantify the proportions of primary 
human PDL cells that can undergo multilineage differentiation and to compare the magnitude of these capa-
bilities relative to bone marrow-derived mesenchymal stem cells (MSCs) and parental PDL (PPDL) cells. PDL 
mesenchymal progenitor (PMP) cells were isolated from PPDL cells using the markers STRO-1 and CD146. The 
colony- forming effi ciency and multilineage differentiation potential of PMP, PPDL, and MSCs under chondro-
genic, osteogenic, and adipogenic conditions were determined. Flow cytometry revealed that on average 2.6% 
of PPDL cells were STRO-1+/CD146+, whereas more than 63% were STRO-1−/CD146−. Colony-forming effi ciency 
of STRO-1+/CD146+ PMP cells (19.3%) and MSCs (16.7%) was signifi cantly higher than that of PPDL cells (6.8%). 
Cartilage-specifi c genes, early markers of osteoblastic differentiation, and adipogenic markers were signifi cantly 
upregulated under appropriate conditions in PMP cells and MSCs compared to either their noninduced coun-
terparts or induced PPDL cells. Consistent with these fi ndings, immunohistochemistry revealed substantial 
accumulation of cartilaginous macromolecules, mineralized calcium nodules, and lipid vacuoles under chon-
drogenic, osteogenic, or adipogenic conditions in PMP and MSC cultures, respectively, compared to noninduced 
controls or induced PPDL cells. Thus STRO-1+/CD146+ PMP cells demonstrate multilineage differentiation ca-
pacity comparable in magnitude to MSCs and could potentially be utilized for regeneration of the periodontium 
and other tissues.
Introduction
The functional periodontal attachment apparatus anchors the teeth to the alveolar bone and consists of 
periodontal ligament (PDL) connective tissue fi bers running 
between the bone and cementum that lines the root surface 
[1,2]. These fi bers help the tooth withstand pathophysiolog-
ical forces that occur during mastication [3]. The PDL con-
tains several cell types, including fi broblasts, which are the 
most numerous, epithelial cells, endothelial cells, infl amma-
tory cells, and neural and lymphatic cells. These cells are im-
portant in fulfi lling the multiple roles of the PDL including 
the elaboration of an extracellular matrix and collagen fi ber 
formation for load bearing and structural requirements. 
Since the PDL has one of the highest metabolic turnover rates 
in the body [4,5], PDL cells must also participate and con-
tribute substantially to its renewal. Finally, PDL cells are in-
tricately involved in repair and regeneration of these tissues 
following surgical wounding and after its breakdown in in-
fl ammatory periodontal disease. Thus the PDL is a complex 
structure of connective tissue collagen fi bers, other extracel-
lular matrix proteins, and a heterogenous group of cells nec-
essary for the many functions of the PDL tissues.
Periodontitis is a collective name for infl ammatory dis-
eases affecting the tissues that surround and support teeth. 
If left untreated, periodontitis often causes progressive bone 
loss around teeth, mobility of teeth and eventually tooth loss 
[3]. Although it is highly prevalent, the precise mechanisms 
that govern this disease and the regenerative processes that 
recapitulate the lost tissues following disease have not been 
fully characterized. Precipitating factors, such as microor-
ganisms and their byproducts, initiate an infl ammatory 
process that leads to the dissolution of tissue components 
in a susceptible host. Furthermore, the complex structures 
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of the periodontium, which consists of the soft connective 
tissues of the gingiva and PDL and the mineralized  tissues, 
cementum, and bone, make periodontal regeneration a very 
complicated and unique process. Periodontal regeneration 
requires the formation of new periodontal fi bers, the or-
chestrated and simultaneous formation of new bone, and 
the coordinated insertion of the newly formed fi bers into 
the regenerating cementum and bone. Consequently, both 
the complexity of the PDL attachment apparatus and the 
heterogeneity of its cell population complicates efforts in 
dissecting out the precise mechanisms of tissue breakdown 
and in identifying the cells necessary for the complete re-
generation of these tissues following disease. As a result, 
currently the complete regeneration of all these periodontal 
tissues is  clinically unpredictable, resulting at best in only 
partial regeneration of some of the tissues [2].
The heterogeneity of the PDL cell population and the 
 spatial and temporal processing of these cells to differenti-
ate into appropriate cell types remains one of the key factors 
in implementing optimal approaches to periodontal regen-
eration. From a cell-therapy standpoint, future prospects for 
improved periodontal regeneration will rely on the ability 
to identify specifi c subtypes of PDL cells that are capable 
of proliferation and differentiation into various tissues by 
specifi c spatially and temporally regulated exogenous cues 
[6,7]. Given this, previous studies have isolated cells termed 
multipotent postnatal stem cells from the PDL by single 
colony selection and magnetic activated cell sorting using 
one of the early mesenchymal stem cell (MSC) surface mark-
ers STRO-1 [8]. Similarly, the ability of putative stem cells 
derived from human PDL for multidifferentiation poten-
tial have been determined by using a mixed population of 
STRO-1+/CD146− and STRO-1+/CD146+ cells [9]. No previous 
attempts have been made to determine the capability and 
potency of STRO-1+/CD146+ double positive PDL cells to 
differentiate into different lineages. The successful isolation 
of such cells that we refer to as periodontal mesenchymal 
progenitor (PMP) cells from parental PDL (PPDL) cells is 
likely to augment both the purity of this unique cell pop-
ulation and their ability for multilineage potential possibly 
mimicking that of bone marrow-derived MSCs. Therefore, 
the purpose of this study was to determine the proportion 
of primary PDL cells that are STRO-1+/CD146+ and can un-
dergo multilineage differentiation, and to compare the mag-
nitude of these capabilities relative to MSCs and PPDL cells. 
This work will help lay a substantial foundation toward 
understanding the fundamental molecular mechanisms in 
the regeneration of periodontal and craniofacial structures. 
Also knowing the relative abundance of these cells present 
in any given parental population of PDL cells will enhance 
our knowledge for improved clinical outcomes.
Materials and Methods
Subjects, tissue collection, and cell culture
PDL cells were retrieved from healthy premolars 
extracted for orthodontic reasons (n = 8) and impacted third 
molars (n = 4) from 6 individuals (16–25 years old) under 
informed consent at the University of Michigan School of 
Dentistry. PDL tissues were carefully dissected and re-
trieved from the middle third of the root surfaces of extracted 
teeth under sterile conditions as previously described [10]. 
The explants were minced and covered with sterile glass 
 coverslips in 35-mm tissue culture dishes in α-minimal es-
sential media (α-MEM) supplemented with 10% fetal bovine 
serum (FBS), 1% penicillin–streptomycin, and fungizone 
(Invitrogen Corp., Carlsbad, CA, USA) in a humidifi ed at-
mosphere (37ºC, 5% CO2). After the outgrowth of PDL cells 
reached confl uency, they were expanded twice until suffi -
cient cells were obtained for subsequent procedures.
Flow cytometric analysis of stem cell surface 
markers on PDL cells
Single cell suspensions were obtained by detaching mono-
layers of PDL cells with cell dissociation buffer (Invitrogen 
Corp.) and fi ltering the cell suspension through 40 μm 
nylon cell strainers (BD Biosciences, Bedford, MA, USA). 
Cells (1 × 106) were incubated with a mouse antihuman 
monoclonal STRO-1 primary antibody (R&D Systems Inc., 
Minneapolis, MN, USA) in 2% FBS/PBS for 1 h. After three 
washes with 2% FBS/PBS, the cells were incubated with 
FITC-conjugated goat antimouse IgM secondary antibody 
(BioFX Laboratories Inc., Owings Mills, MD, USA) for 30 
min. Cells were washed, incubated with R-Phycoerytherin 
(PE)-conjugated mouse antihuman CD146 monoclonal (BD 
Biosciences) antibody for 30 min, fi xed in BD Cytofi x buffer 
(BD Biosciences) for 30 min, washed, and resuspended in 
500 μL PBS. For negative controls, PE-conjugated nonspecifi c 
mouse IgG (BD Biosciences) or nonspecifi c mouse serum 
(OncogeneTM, Cambridge, MA, USA) were substituted for 
the primary antibodies. All the above procedures were per-
formed in the dark at 4°C. The expression profi le of STRO-1 
and CD146 on PDL cells was examined using fl ow cytometry 
(Becton-Dickinson, San Jose, CA, USA) and analyzed with 
Cell-Quest 3.1 software (Becton-Dickinson). To characterize 
the proportion of MSCs that are positive for STRO-1 and/or 
CD146, these procedures were repeated on MSCs.
Immuno-magnetic Dynabead cell sorting
To isolate the PMP cells from the PPDL cell population, 
the CELLection Biotin Binder kit and the Dynal MPC-1 
(Invitrogen Corp.) system were employed as per the manu-
facturer’s instructions. Detached PDL cells (1 × 107) were in-
cubated with mouse antihuman monoclonal STRO-1 primary 
antibody for 60 min on ice, while the biotin conjugated goat 
antimouse IgM secondary antibody (BioFX Laboratories) was 
mixed with the streptavidin-bound magnetic Dynabeads for 
30 min at room temperature. PDL cells were then thoroughly 
washed and resuspended in 1 mL Buffer 2 (PBS with 0.1% 
BSA and 0.6% Na-citrate) and mixed well with the appro-
priate volume of Dynabead-bound biotin conjugated goat 
antimouse IgM secondary  antibody for 20 min at 4°C with 
gentle mixing. Subsequently, the Dynabead-bound cells were 
washed three times with Buffer 1 and resuspended in 200 
μL preheated (37°C) Buffer 3 (RPMI 1640 with 1% fetal calf 
serum, 1 mM CaCl2, and 4 mM MgCl2, pH 7.0–7.4). Following 
this, 4 μL of Releasing Buffer were added and incubated with 
the  Dynabead-bound cells for 15 min at room temperature 
with gentle mixing. The  mixture was then transferred to the 
Dynal MPC-1 magnet for 2 min. The supernatants contain-
ing the released STRO-1 positive cells were collected and 
plated in MSC growth media for approximately 1 week after 
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which the STRO-1 positive cells were detached and subjected 
to a second  isolation with a biotinylated mouse antihuman 
CD146 antibody using the procedures described above. The 
isolated STRO-1 and CD146 double positive PMP cells were 
then plated for up to 3 weeks prior to subsequent experimen-
tation. In addition, cells from three individuals were simi-
larly isolated and cultured for subsequent fl ow cytometric 
anaylsis to determine the proportion of cells that remained 
double positive for STRO-1+/CD146+ at the beginning of the 
differentiation experiments.
Colony-forming efficiency assay
Four-hundred Dynabead-sorted STRO-1+/CD146+ PMP 
cells and the same number of corresponding PPDL cells and 
bone marrow MSCs (Cambrex Bio Science, Walkersville, MD, 
USA) were plated in 100 mm tissue-culture plates in MSC 
growth media for 10 days. The newly formed colonies were 
visualized using 0.1% (w/v) toluidine blue  (Sigma-Aldrich, 
St. Louis, MO, USA) staining following 1% paraformalde-
hyde fi xation. Aggregates of more than 50 cells were scored 
as colonies [11]. Colony-forming effi ciency was determined 
by the number of colonies relative to the total number of 
seeded cells in each plate.
Chondrogenic, osteogenic, and adipogenic cultures 
of PPDL cells, PMP cells, and MSCs
To characterize the ability of PMP cells to undergo 
 multilineage differentiation in comparison to that of the 
PPDL cells and MSCs, all cells were subjected to chondro-
genic-, osteogenic-, and adipogenic-induction, as previously 
described [12–16].
A pellet culture system was used for chondrogenic dif-
ferentiation. Approximately 2 × 105 PPDL cells, PMP cells, 
or MSCs were placed in a 15-mL conical polypropylene tube 
and pelleted under centrifugation at 500G for 10 min. The 
pellet was cultured in 500 μL chemically defi ned growth 
medium with l-gluatamine, penicillin–streptomycin, and 
10% FBS or chemically defi ned serum-free chondrogenic 
induction medium containing dexamethasone, ascorbate, 
insulin–transferrin–sodium selenite (ITS), sodium pyruvate, 
proline, l-glutamine, and TGF-β3, purchased from Cambrex 
Bio Science. The medium was replaced every 3 days for up 
to 21 days.
For osteogenic and adipogenic differentiation, each of the 
cell types were initially plated in monolayers at 3 × 103/cm2 
(osteogenic) or 2 × 104/cm2 (adipogenic) in growth media 
containing l-glutamine, penicillin/streptomycin, and 10% 
FBS. For the osteogenic assays, cells were cultured in either 
the growth media (controls) or in the osteogenic induction 
media containing l-glutamine, ascorbate, dexamethasone, 
and β-glycerophosphate for 2–3 weeks according to man-
ufacturer’s instructions. For adipogenesis, cells grown to 
confl uence were subjected to three cycles of induction and 
maintenance for optimal adipogenic differentiation fol-
lowing manufacturer’s instruction. Each cycle consisted of 
feeding cells with the adipogenic induction media for 3 days 
followed by 3 days of culture in the maintenance media. The 
adipogenic induction media contained recombinant human 
insulin, dexamethasone, indomethacin, l-glutamine, and 
3-isobutyl-1-methylxanthine, whereas the adipogenic 
maintenance media contained only recombinant human in-
sulin and l-glutamine. Cells in the control group were main-
tained only in the maintenance media on the same schedule. 
All growth media, osteogenic induction media, adipogenic 
maintenance media, and adipogenic induction media were 
purchased from Cambrex Bio Science.
Total RNA extraction and qRT-PCR analyses
RNeasy Mini kit (Qiagen Corp., Valencia, CA, USA) was 
used to extract total RNA from PPDL cells, PMP cells, and 
MSC monolayer cultures on day 5 for osteogenic and day 7 
for adipogenic gene assays. For the chondrogenic gene ex-
pression studies, total RNA was extracted on day 7 from 
high-density pellet cultures with Trizol reagent (Invitrogen 
Corp.). Total RNA (1 μg) from each condition was reverse-
transcribed using the Omniscript RT Kit (Qiagen Corp.). A 
1:100 dilution of the resulting cDNA was utilized as a tem-
plate to quantify the relative content of mRNA by qRT-PCR 
(Applied Biosystems, Carlsbad, CA, USA). Primers specifi c for 
human collagen type II (forward primer: 5′-GGA AGA GTG 
GAG ACT ACT GGA TTG AC-3′, reverse primer: 5′-TCC ATG 
TTG CAG AAA ACC TTC AT-3′), cartilage oligomeric ma-
trix protein (COMP; forward primer: 5′-GAC AGT GAT GGC 
GAT GGT ATA GG-3′, reverse primer: 5′-TCA CAA GCA TCT 
CCC ACA AAG T-3′), and 18s rRNA (forward primer: 5′-CGC 
CGC TAG AGG TGA AAT TC-3′, reverse primer: 5′-CAT TCT 
TGG CAA ATG CTT TCG-3′) were designed with Primer 
Express 2.0 (Applied Biosystems). Primers specifi c for oste-
ogenic- and osteoblast-related markers (osterix and alkaline 
phosphatase) and adipogenic markers [lipoprotein lipase 
(LPL) and peroxisome proliferation-activated receptor-γ2 
(PPAR-γ2)] were purchased from Applied Biosystems. PCR 
reactions were performed with the SYBR green PCR master 
mix kit (Applied Biosystems). As an internal control, 18s 
rRNA was used. Cycle threshold values of the genes of in-
terest and the quantitative gene expression levels relative to 
18s rRNA in the samples were determined as per the manu-
facturer’s instructions (Applied Biosystems).
Alkaline phosphatase activity assays
An alkaline phosphatase activity assay was used to assess 
osteogenic differentiation in day 7 cultures of all cell types. 
This activity was measured in cell lysates by enzymatic con-
version of p-nitrophenylphosphate (pNPP; Sigma-Aldrich) 
to p-nitrophenol as previously described [10]. The amount 
of p-nitrophenol produced was measured spectrophoto-
metrically (Molecular Devices, Sunnyvale, CA, USA) at a 
wavelength of 405 nm against a standard curve. The results 
were standardized by the total amount of protein in the cell 
lysates. The total amount of protein in the cell lysates was 
determined using the BCA protein assay kit according to the 
manufacturer’s instructions (Pierce, Rockford, IL, USA).
Histochemistry and immunohistochemistry
The chondrogenic pellets were rinsed in PBS, fi xed 
with 4% paraformaldehyde/PBS, embedded in paraffi n, 
and cut through the center to obtain 5-μm sections. Newly 
synthesized glycosaminoglycans (GAGs) were evaluated 
by Safranin-O (Sigma-Aldrich) staining and imaged by 
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photomicrography (Nikon TS100, Tokyo, Japan) as described 
elsewhere [17].
To localize collagen type II and aggrecan in the chon-
drogenic pellets, sections were rehydrated prior to immu-
nostaining with the Histostain-SP kit (Invitrogen Corp.). To 
expose epitopes, sections were pretreated with either chon-
droitinase ABC for aggrecan staining or pepsin for collagen 
type II staining. Endogenous peroxidase was quenched, sec-
tions were incubated with a blocking solution for 10 min, 
followed by incubation with primary antibodies specifi c 
for human collagen type II (Chemicon International Inc., 
Temecula, CA, USA) or aggrecan (Abcam Inc., Boston, MA, 
USA) for 3 h at 37°C. Negative control sections were incu-
bated with nonimmune serum. Sections were washed, incu-
bated with biotinylated secondary antibody, washed again, 
and incubated with a streptavidin–peroxidase conjugate. 
Following further washing, sections were incubated with a 
diaminobenzidine solution and counterstained with hema-
toxylin. Specimens were observed and imaged under a mi-
croscope (Nikon TS100).
Osteogenic monolayer cultures were stained for matrix 
mineralization with Alizarin red S (Sigma-Aldrich) stain-
ing on day 14 as described previously [18]. In brief, cultures 
were fi xed with 70% ethanol for 10 min and stained with 2% 
Alizarin red S solution (pH 4.0) for 5 min at room temper-
ature. To quantify the degree of calcium accumulation in 
the mineralized extracellular marix, Alizarin red S–stained 
cultures were incubated with 100 mM cetylpyridinium 
chloride (Sigma-Aldrich) for 1 h to release calcium-bound 
dye into solution. The absorbance of the released dye was 
measured at 570 nm using a spectrophotometer (Molecular 
Devices) and standardized by the total amount of protein 
in the culture.
Lipid vacuole formation in the adipogenic cultures was 
determined by Oil Red O (Sigma-Aldrich) staining on day 
18. The cells were gently rinsed with PBS and fi xed with 4% 
paraformaldehyde in PBS for 1 h, rinsed with ddH2O, and 
incubated with 60% isopropanol for 5 min, and stained with 
the Oil Red O working solution (30 mL of 3 mg/mL Oil Red 
O/isopropanol stock solution plus 20 mL ddH2O) for 5 min 
at room temperature. After rinsing with water, the cultures 
were counterstained with haematoxylin for 1 min at room 
temperature, rinsed again, and observed with phase con-
trast microscopy (Nikon TS100).
Statistical analysis
The mean ± standard deviation of data from experi-
ments performed in triplicate for three to six independent 
samples were plotted as histograms for each quantitative 
variable. The statistical signifi cance of any differences was 
determined by one-way analysis of variance (ANOVA) with 
the signifi cance set at P < 0.05.
Results
A small proportion of PDL cells are 
presumptive PMP cells
Among the MSC surface markers available [8,9,16,19], 
STRO-1 and CD146 were selected for identifi cation of the 
putative PMP cells in the PDL, because these markers have 
been used successfully in the past. Flow cytometric data 
showed a wide interindividual variability in the proportion 
of cells that were positive for both markers, one of the two 
markers, or double negative for both markers. On average 
2.6% of PPDL cells were STRO-1+/CD146+ or presumptive 
PMP cells, whereas more than 63% were double negative 
for these markers (Fig. 1A and B). For the remainder of the 
cells, more than 31% were STRO-1−/CD146+ whereas only 
2.6% were STRO-1+/CD146− suggesting a potentially mixed 
phenotype and limited multilineage differentiation poten-
tial in these cells. Based on these fi ndings and previous 
reports [8,20,21], the putative PMP cells present within the 
PDL represent only a small subset of the whole popula-
tion of PDL cells. We also found that more than 12% of the 
MSCs were STRO-1+/CD146+, whereas STRO-1+/CD146−, 
and STRO-1−/CD146+ cells comprised more than 13% and 
1% of MSCs, respectively, which are higher than reported 
 previously for general bone marrow stromal cells [22–24] 
(Fig. 1A).
To assess the stability of the STRO-1/CD146 makers on 
the PMP cells, fl ow cytometry was performed on cells pu-
rifi ed for STRO-1+/CD146+ from three individuals and cul-
tured for 3 weeks. These experiments demonstrated that on 
the average more than 67% (SD ± 23%) of the isolated PMP 
cells remained STRO-1+/CD146+ before we commenced our 
experiments for multilineage induction (Fig. 1C). These data 
indicate that the double positive PMP cells retain relatively 
stable stem cell surface marker expression over the short 
term in culture and with passage.
PMP cells form clonogenic cell colonies with 
equivalent efficiency to that of MSCs
To determine whether the isolated STRO-1+/CD146+ 
cells or presumptive PMP cells possess the characteristics 
of MSCs, they were examined for their ability to form stem 
cell-like adherent clonogenic cell clusters in colony-forming 
assays. PMP cells were also compared to their PPDL counter-
parts and to bone marrow-derived MSCs. PMP cells showed 
slightly, but not signifi cantly, higher levels of colony form-
ing effi ciency (19.3%) relative to MSCs (16.7%) (Fig. 1D). Both 
these cell types had signifi cantly greater (P < 0.01) colony-
forming effi ciency than the PPDL cells (6%).
PMP cells exhibit osteoblastic marker expression, 
alkaline phosphatase activity, and mineralization 
similar to MSCs and higher than PPDL cells
qRT-PCR analyses on RNA from PMP cells, the corre-
sponding PPDL cells, and MSCs placed in osteogenic induc-
tion media revealed that gene expression of both osterix 
and alkaline phosphatase, the early osteoblastic differen-
tiation and mineralization markers, respectively, were sig-
nifi cantly upregulated (P < 0.01) in osteogenically induced
PMP cells and MSCs compared to their noninduced coun-
terparts (Fig. 2A and B). Specifi cally, osterix expression 
levels were 2.3-fold and 2.6-fold greater while alkaline 
phosphatase levels were 22.5-fold and 38-fold greater in 
PMP cells and MSCs, respectively, than in their noninduced 
controls. Moreover, the levels of these two genes were also 
signifi cantly higher (P < 0.01) in the induced PMP cells 
and MSCs than that in the noninduced and osteogenically
induced PPDL cells.
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The upregulation of alkaline phosphatase gene expres-
sion in osteogenically induced PMP cells and MSCs was 
paralleled by a similar increase in alkaline phosphatase
activity in these cells (Fig. 2C). Osteogenically induced PMP 
cells exhibited approximately 15-fold and 7-fold increase 
in alkaline phosphatase activity compared to noninduced 
and induced PPDL cells, respectively. Similarly, osteogeni-
cally induced MSCs exhibited ∼60-fold and 30-fold increase 
in alkaline phosphatase activity compared to noninduced 
and induced PPDL cells, respectively. Alkaline phosphatase 
activity in osteogenically induced PPDL cells was increased 
slightly relative to that in noninduced PPDL cells.
Alizarin red S staining corroborated the fi ndings that 
PMP cells have a greater osteoblastic potential than their 
PPDL counterparts. Both PMP and MSC cultures exhibited 
obvious accumulation of calcium-containing mineralized 
nodules after 2 weeks of osteogenic induction, whereas the 
accumulation of mineralized nodules in the induced PPDL 
cell cultures was barely discernible (Fig. 3A). The released 










































































































































FIG. 1. Isolation and characterization of PDL mesenchymal progenitor (PMP) cells and evaluation of their stem cell-like 
self-renewal ability. (A) The proportions of STRO-1 and CD146 double positive, single positive, and double negative PDL 
cells from six individuals was determined by examining the surface expression profi les of these stem cell surface mark-
ers using fl ow cytometry. Female (F) and male (M) subjects ranged from 16 to 25 years of age. The proportions of STRO-1 
and CD146 double positive, single positive, and double negative mesenchymal stem cells (MSCs) was determined by 
examining the surface expression profi les of these stem cell surface markers using fl ow cytometry. (B) The mean percent 
of STRO-1 and CD146 double positive, single positive, and double negative cells was calculated and depicted graphically. 
(C) The stability of STRO-1 and CD146 double positive PMP cells prior to commencing the differentiation experiments was 
determined from a subset of three individuals. The STRO-1 single positive cells were isolated, expanded for 1 week before 
the CD146+ cells were secondarily isolated, and expanded for further 3 weeks before being assayed by fl ow cytometry.
(D) Assays performed to assess stem cell-like adherent clonogenic cell clusters formed in colony-forming assay plates by the 
presumptive PMP cells, the counterpart PPDL cells, and bone marrow-derived MSCs showed a high number of colonies for 
PMP cells and MSCs but not for PPDL cells. Newly formed colonies were stained with toluidine blue. Histogram depicting 
the colony-forming effi ciency for cells were quantifi ed from colony-forming assays. The colony-forming effi ciency was de-
termined as the number of colonies standardized by the total number of seeded cells in each plate. Aggregates of more than 
50 cells were scored as colonies. Data, expressed as mean ± SD, were obtained from experiments performed in triplicate for 
three independent cultures (*P ≤ 0.01 for PMP or MSC compared to PPDL).
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12-fold higher in induced PMP cell and MSC cultures, re-
spectively, compared to that in noninduced or induced PPDL 
cell cultures (Fig. 3B).
Stimulated PMP cell and MSC pellets 
exhibit increased cartilage-specifi c 
gene and protein expression
To examine the potential for the PMP cells to differen-
tiate down a chondrogenic lineage, the STRO-1+/CD146+ 
cells were studied for their ability to upregulate their ex-
pression of the cartilage-specifi c genes, collagen type II, and 
COMP. Gene expression for both cartilage specifi c markers 
was signifi cantly higher in chondrogenically induced PMP 
cells and MSCs cells than their corresponding noninduced 
controls on day 7 (Fig. 4A and B). However, PPDL cells cul-
tured in chondrogenic media showed minimal increase in 
these genes relative to noninduced controls. Specifi cally, 
the increase in collagen type II was approximately 2.6-fold 
and 4.3-fold greater in chondrogenically induced PMP cells 
and MSCs, respectively, relative to both noninduced and in-
duced PPDL cells. Similarly, COMP was 7-fold and 35-fold 
higher in chondrogenically stimulated PMP cells and MSCs 
compared to noninduced PPDL cells. 
Safranin-O staining for newly synthesized GAGs, 
which is a component of cartilage-specifi c proteoglycans 
was observed in both chondrogenically induced PMP cell 
and MSC pellets (Fig. 5A). In contrast, PPDL cell pellets 
from both the induced and noninduced cells displayed no 
staining of these cartilage specifi c ECM macromolecules. 
Consistent with these fi ndings, immunohistochemical ex-
amination of the cartilage specifi c ECM proteins aggrecan 
and collagen type II in cell pellets showed substantial stain-
ing for both macromolecules in chondrogenically induced 
PMP cell and MSC pellets, whereas neither collagen type II 
nor aggrecan was detected in sections of noninduced PPDL, 
PMP, or MSC pellet cultures (Fig. 5B and C). Interestingly, 
minimal positive staining for aggrecan and collagen type 
II was found in chondrogenically induced sections of PPDL 
cell pellets.
PMP cells and MSCs but not PPDL cells express 
adipocytic markers and accumulate lipid vacuoles 
under adipogenic conditions
PMP cells stimulated with adipogenic media showed a 
450-fold increase in LPL and a 7-fold increase in PPAR-γ2 
compared to their noninduced counterparts or PPDL cells 
(Fig. 6A and B). Similarly, MSCs exhibited a 15,000-fold and 
60-fold increase in LPL and PPAR-γ2,  respectively, relative to 
their noninduced counterparts or PPDL cells.
Oil red O staining to visualize the accumulation of lipid 
vacuoles within the cytoplasm revealed staining in adipo-
genically induced PMP cells and MSCs but not the induced 
or noninduced PPDL cells (Fig. 6C). It is also notable that 
the adipogenically induced MSCs had much higher adi-
pogenic marker gene expression for both LPL and PPARγ2 
and stronger Oil red O staining than that of induced PMP 
cells, demonstrating much more robust adipogenic ability in 
MSCs relative to both PMP and PPDL cells. 
Discussion
In this study, we found that on the average 2.6% of PDL 
cells present within all patient and tooth samples were pos-
itive for the stem cell surface markers STRO-1 and CD146. 
On the basis of these fi ndings and those of others [8,20,21], 
we used STRO-1 and CD146 as selection markers for isola-
tion of the putative PMP cells from parental pools of pri-
mary PDL cell cultures. This small subset of PMP cells was 
indeed shown to possess a stronger self-renewal ability and 
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FIG. 2. Osteoblastic gene expression and alkaline phosphatase activity is induced in PMP cells and MSCs by osteogenic 
media (Ost Media). (A) Mean ± SD relative expression levels of osterix (A) and alkaline phosphatase (B) mRNA measured 
by qRT-PCR in noninduced (−) and induced (+) PPDL cells, PMP cells, and MSCs on Day 5 of culture. (C) Histograms of
mean ± SD alkaline phosphatase activity in noninduced and osteoblastically induced PPDL cells, PMP cells, and MSCs 
on Day 7 of culture. Alkaline phosphatase activity was quantifi ed spectrophotometrically and standardized by the total 
amount of protein in the cell lysate. Data were obtained from experiments performed in triplicate on three independent 
cultures (*P ≤ 0.01 for osteoblastically induced PMP cells or MSCs compared to noninduced PMP cells, MSCs, or PPDL cells, 
or osteoblastically induced PPDL cells).
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osteogenic, chondrogenic, and adipogenic conditions be-
yond that of the PPDL cells. Furthermore, relative to MSCs 
these PMP cells have largely comparable capabilities of self-
renewal and osteogenic differentiation and somewhat lower 
but still robust capabilities to differentiate into chondrocytes 
and adipocytes. Overall, our fi ndings suggest that these PMP 
cells selected with a limited number of stem cell markers re-
present a unique subpopulation of cells within the PDL that 
possess several MSC-like properties.
Attempts to isolate and characterize mesenchymal pro-
genitor cells from tooth structures including dental pulp, 
periapical follicle, and PDL have spanned several years. 
These attempts have mimicked methodologies used for iso-
lation of stem cells from the bone marrow. Previous studies 
have employed different single stem cell surface markers 
such as STRO-1, CD29, CD44, CD105, CD106, CD146, or CD166 
to isolate dental pulp and PDL stem cells (PDLSCs) [11,25,26]. 
Stem cell surface marker expression profi le has been used 
to isolate human dental pulp stem cells, which were then 
shown to also express CD44, CD146, integrin β1, and STRO-1 
[25]. These investigators further isolated ovine PDLSCs by 
using MSC-associated antigen CD106. These ovine PDLSCs 
exhibited a high proliferation rate in vitro and expressed a 
phenotype (CD44+, CD166+, CBFA-1+, collagen-I+, bone sia-
loprotein+) consistent with that of human-derived PDLSCs 
[11]. Similarly, postnatal stem cells from human dental tis-
sues (dental pulp, PDL, and periapical follicle) isolated using 
STRO-1 as a stem cell marker have been shown to also ex-
press other MSC markers including CD29 and CD44 [26].
Given the fact that a single specifi c stem cell marker for
MSCs is not currently available and the isolated dental stem
cells often express multiple stromal cell markers at varied 














































FIG. 3. PMP cells and MSCs but not PPDL cells cultured in 
osteogenic media show increased deposition of mineralized 
ECM. (A) Images of monolayer cultures of PPDL cells, PMP 
cells, and MSCs incubated in control or osteogenic media 
(Ost Media) for 14 days stained with Alizarin red S stain-
ing shows substantial staining in the induced PMP cells and 
MSCs but not PPDL cells. (B) The amount of calcium depo-
sition in the mineralized ECM was quantitated by releasing 
the calcium-bound alizarin red into solution, measured spec-
trophotometrically, and standardized by the total amount 
of protein in each culture. The mean ± SD for experiments 
performed in triplicate on three independent cultures is pre-
sented as a histogram (*P ≤ 0.01 for osteoblastically-induced 
PMP cells or MSCs vs. noninduced PMP cells, MSCs, or 
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FIG. 4. Chondrogenic media enhances the expression of 
cartilage-specifi c genes in PMP cells and MSCs but not in 
PPDL cells. Cells were cultured in pellet, exposed to con-
trol or chondrogenic media (Chondro Media) for 7 days, 
and the RNA retrieved and assayed for collagen type II (A) 
and COMP (B) by qRT-PCR. Data, expressed as mean ± SD, 
were obtained from experiments performed in triplicate on 
three independent cultures (*P ≤ 0.01 for chondrogenically-
induced PMP cells or MSCs vs. noninduced PMP, MSC, or 
PPDL cultures, or chondrogenically induced PPDL cultures).
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stem cell markers for the isolation of more specifi c PMP 
cells. Indeed, multipotent stem cells from human PDL 
isolated for early stem cell surface marker STRO-1 were 
also shown to strongly express CD146 and the isolated 
cells were able to differentiate into cementoblast-like cells, 
adipocytes, and fi broblast-like cells [8]. Transplantation 
of these cells into artifi cially created periodontal defects 
in rats showed that these cells had the capacity to gen-
erate a thin layer of cementum-like tissue on the surface 
of hydroxyapatite or tricalcium phosphate ceramic par-
ticles along with the condensed collagen fi bers resem-
bling Sharpey’s fi bers. However, the stem cell properties 
of isolated PMP cells relative to their PPDL cell pools, and 
their comparative ability for multilineage differentiation 
 relative to the available gold-standard of MSCs have not 
been fully delineated. Thus this became the goal of the 
current investigation.
In our study, PMP cells were isolated from their  parental 
pools of PDL cells using the combined selection markers 
STRO-1 and CD146, but the temporal stability of these cell 
surface markers was not known. Therefore, we sought to de-
termine the short-term stability of STRO-1 and CD146 in our 
PMP cells. We found that a high proportion of the isolated 
STRO-1+/CD146+ PMP cells retain their surface markers over 
the short time in culture and with passage. Thus our data in-
dicate a relatively stable stem cell surface marker expression 
in PMP cells over the short term, which is in agreement with 
the known continuous growth and passage ability of plurip-
otent progenitor cells.
The colony-formation assay data indicate that the 
 isolated PMP cells possess a signifi cantly higher colony-
forming  ability than their PPDL cells providing evidence 
for their  mesenchymal progenitor cell-like quality. This 
 colony-forming ability was similar to that of MSCs. Our 
data further confi rmed the stem cell-like properties of the 
isolated PMP cells by examining their their multilineage 
differentiation potential. In agreement with previous stud-
ies [19,27], our isolated PMP cells were able to undergo 
chondrogenic and osteogenic differentiation as evidenced 




















FIG. 5. Chondrogenic con-
ditions increase the levels of 
cartilaginous ECM in PMP 
cell and MSC pellets. Cell pel-
lets were cultured as described 
in Figure 4 for 21 days, the 
pellets fi xed, sectioned, and 
stained. (A) Representative 
photomicrographs of sections 
stained with Safranin-O show 
substantial amounts of stain-
ing for newly synthesized gly-
cosaminoglycans in induced 
PMP and MSC pellets but not 
in noninduced PMP, MSC, or 
PPDL pellets, or chondrogen-
ically-induced PPDL pellets.
Sections of the pellets im-
munostained for aggrecan
(B) and collagen type II (C) 
also demonstrate high levels of 
staining for these macromol-
ecules in chondrogenically-
induced PMP and MSC pellets
but not in any noninduced 
pellets. Images were captured 
under 40× magnifi cation (Bar 
represents 50 μm).
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(collagen type II, COMP, aggrecan and glycosaminoglycan) 
and osteoblastic differentiation markers (osterix, alkaline 
phosphatase, and matrix mineralization). The chondro-
genic potential of PMP cells, although lower than that of 
MSCs, was still very substantial. In contrast, although PMP 
cells exhibited a higher adipocyte  differentiation  ability 
than their corresponding PPDL cells, the potential for adi-
pogenic differentiation in PMP cells was notably lower than 
that of MSCs. Thus this predilection of PMP cells toward 
a more osteogenic and chondrogenic differentiation phe-
notype indicates that the cells selected are further along 
in their differentiation pathway towards skeletal  tissue 
cell types rather than being highly undifferentiated MSCs 
with equal capacity to differentiate into all mesenchymal 
cell types. These fi ndings also refl ect that the former dif-
ferentiation pathways toward differentiation into skel-
etal cell phenotypes are more critical than adipogenesis 
to the physiologic functioning, repair, and regeneration 
needs of the PDL than differentiation pathways that favor 
adipogenesis.
In summary, using the combined stem cell surface 
markers STRO-1 and CD146 and the culture and isolation 
methods described here, one can expect that a small pro-
portion of primary human PDL cells will be mesenchymal 
progenitor cells. Using these markers, we successfully iso-
lated mesenchymal progenitor cells from human PDL and 
characterized their multilineage differentiation potential 
toward a chondrogenic, osteoblastic, and adipogenic phe-
notype under defi ned conditions. Similar to MSCs, human 
primary PMP cells have a high self-renewal ability and po-
tent chondrogenic and osteogenic differentiation potential 
that is greater than their PPDL cells. However, their adipo-
genic differentiation potential is considerably less than that 
of MSCs. These fi ndings may help future inquiries for im-
proved regenerative methodologies and improved mecha-






































































FIG. 6. Adipogenic-specifi c genes are upregulated and lipid vacuoles accumulate in adipogenically-induced PMP cells 
and MSCs but not in PPDL cells. (A) Cells were cultured in control media or adipogenic media (Adipo Media) for 7 days, the 
RNA extracted and subjected to qRT-PCR for LPL (A) and PPARγ2 (B), and the relative mean ± SD expression of these genes 
for experiments performed in triplicate on three samples was plotted as histograms. (C) Cells from similar experiments cul-
tured for 18 days were stained with Oil Red O staining and photomicrographed to show accumulated lipid vacuoles. Images 
were captured under 10× magnifi cation (*P ≤ 0.01 for adipogenically-induced PMP cells or MSCs vs. noninduced PMP cells, 
MSCs, or PPDL cells, or adipogenically induced PPDL cultures; Bar represents 100 μm).
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